Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FZ7D4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,623
Award facts
- Contract value 100% obligated
- $11,622.75 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,622.75 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pens. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. Performance is scheduled for completion by May 5, 2025, and work will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to military healthcare programs worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to defense and veteran healthcare systems. The company's extensive portfolio of federal contracts demonstrates its capability to fulfill diverse medical supply requirements through open competition. Under its prime IDC with DLA, AmerisourceBergen supports customers including the Defense Health Agency and U.S. Coast Guard, serving as a primary vendor for pharmaceutical procurement across multiple therapeutic domains. The DLA is planning to establish next-generation Pharmaceutical Prime Vendor Global Program contracts with multiple regional awards, positioning AmerisourceBergen as a key provider in the federal medical supply chain.
Quick answers
Who was awarded contract SPE2DB25FZ7D4?
SPE2DB25FZ7D4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 2, 2025.
How much is contract SPE2DB25FZ7D4 worth?
The government has obligated $11,623 on SPE2DB25FZ7D4.
Is contract SPE2DB25FZ7D4 an order under another contract?
Yes. SPE2DB25FZ7D4 is a delivery order under SPE2DB20D3303, an indefinite delivery contract.
Was contract SPE2DB25FZ7D4 competed?
The extent of competition for SPE2DB25FZ7D4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award